More on MNOV
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.30 |
|
|||
| Open | $1.33 | ||||
| 52 Wk High | $10.16 | ||||
| 52 Wk Low | $2.91 | ||||
| Day High | $1.40 | ||||
| Day Low | $1.30 | ||||
| P/E | N/A | ||||
| EPS | $-0.41 | ||||
| Volume | 40,162 | ||||
- Form 8-K MEDICINOVA INC For: Feb 20
- MediciNova enrolls 100 patients in ALS drug expanded access study
- MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients
- Form 4 MEDICINOVA INC For: Jan 16 Filed by: Matsuda Kazuko
- Form 4 MEDICINOVA INC For: Jan 16 Filed by: IWAKI YUICHI
- 2026 New Year’s Greetings from the CEO
- Lucid Capital Markets Starts MediciNova (MNOV) at Buy
- MediciNova enters $50 million equity distribution agreement with Lucid
- Form 424B5 MEDICINOVA INC
- Form 8-K MEDICINOVA INC For: Dec 29
Entities mentioned with MNOV
- FDA | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- Earnings | View Related Stories »
- Pre Market Movers | View Related Stories »
- S3 | View Related Stories »
- Definitive Agreement | View Related Stories »
- B. Riley | View Related Stories »
- Pre-Open Losers | View Related Stories »
- Show More...
